Manufacturers Life Insurance Company, The Dbv Technologies S.A. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$1.58 - $4.77 $438,061 - $1.32 Million	-277,254 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$3.74 - $6.28 $212,989 - $357,639	56,949 Added 25.85%	277,254 $1.28 Million
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $97,682 - $544,173	-41,924 Reduced 15.99%	220,305 $864,000
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $689,512 - $1.14 Million	102,150 Added 63.81%	262,229 $2.81 Million
Q3 2019 Nov 12, 2019	SELL	$8.57 - $10.72 $409,560 - $512,308	-47,790 Reduced 22.99%	160,079 $1.37 Million
Q2 2019 Aug 14, 2019	BUY	$7.58 - $10.0 $1.58 Million - $2.08 Million	207,869 New	207,869 $1.71 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $824M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.